Abstract P050: Trial in progress: A phase 2 multicenter study of autologous tumor-infiltrating lymphocyte (TIL, LN-145) cell therapy in patients with metastatic non-small cell lung cancer (mNSCLC)

2021 ◽  
Author(s):  
Erminia Massarelli ◽  
Selda Samakoglu ◽  
Viktoria Gontcharova ◽  
Guang Chen ◽  
Madan Jagasia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Multicenter Study ◽  
Small Cell ◽  
Autologous Tumor ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Tumor Infiltrating Lymphocyte

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (1) ◽  
pp. 78-83 ◽  
Author(s):  
Benjamin Besse ◽  
David Planchard ◽  
Anne-Sophie Veillard ◽  
Laurent Taillade ◽  
David Khayat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study

scholarly journals Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium

2017 ◽  
Vol 23 (24) ◽  
pp. 7550-7557 ◽  
Author(s):  
Pawadee Lohavanichbutr ◽  
Lori C. Sakoda ◽  
Christopher I. Amos ◽  
Susanne M. Arnold ◽  
David C. Christiani ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Multicenter Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document